Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis
ConclusionIncidence of seroconversion in MS patients who had been treated with natalizumab is higher in European/American countries than Asian countries.
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research
More News: Brain | Conferences | Multiple Sclerosis | Neurology | Neuroscience | Science | Study | Tysabri